These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 31534970)

  • 21. Guttiferone K impedes cell cycle re-entry of quiescent prostate cancer cells via stabilization of FBXW7 and subsequent c-MYC degradation.
    Xi Z; Yao M; Li Y; Xie C; Holst J; Liu T; Cai S; Lao Y; Tan H; Xu HX; Dong Q
    Cell Death Dis; 2016 Jun; 7(6):e2252. PubMed ID: 27253416
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of S-phase kinase-associated protein 2 (SKP2) on cell cycle status, viability, and chemoresistance in A549 lung adenocarcinoma cells.
    Ishii T; Matsuse T; Masuda M; Teramoto S
    Exp Lung Res; 2004 Dec; 30(8):687-703. PubMed ID: 15700547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. c-myc and skp2 coordinate p27 degradation, vascular smooth muscle proliferation, and neointima formation induced by the parathyroid hormone-related protein.
    Sicari BM; Troxell R; Salim F; Tanwir M; Takane KK; Fiaschi-Taesch N
    Endocrinology; 2012 Feb; 153(2):861-72. PubMed ID: 22210745
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MACC1 silencing inhibits cell proliferation and induces cell apoptosis of lung adenocarcinoma cells through the β-catenin pathway.
    Guo L; Ou S; Ma X; Zhang S; Lai Y
    Neoplasma; 2018; 65(4):552-560. PubMed ID: 29940751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ARHGAP24 inhibits cell proliferation and cell cycle progression and induces apoptosis of lung cancer via a STAT6-WWP2-p27 axis.
    Wang L; Shen S; Xiao H; Ding F; Wang M; Li G; Hu F
    Carcinogenesis; 2020 Jul; 41(5):711-721. PubMed ID: 31430374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The study of effect and mechanism of 630-nm laser on human lung adenocarcinoma cell xenograft model in nude mice mediated by hematoporphyrin derivatives.
    Lin C; Zhang Y; Wang J; Sui A; Xiu L; Zhu X
    Lasers Med Sci; 2020 Jul; 35(5):1085-1094. PubMed ID: 31642999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Knockdown of STIM1 expression inhibits non-small-cell lung cancer cell proliferation
    Ge C; Zeng B; Li R; Li Z; Fu Q; Wang W; Wang Z; Dong S; Lai Z; Wang Y; Xue Y; Guo J; Di T; Song X
    Bioengineered; 2019 Dec; 10(1):425-436. PubMed ID: 31564210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. C-Myc participates in β-catenin-mediated drug resistance in A549/DDP lung adenocarcinoma cells.
    Xie C; Pan Y; Hao F; Gao Y; Liu Z; Zhang X; Xie L; Jiang G; Li Q; Wang E
    APMIS; 2014 Dec; 122(12):1251-8. PubMed ID: 25131138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemical study of Skp2 and Jab1, two key molecules in the degradation of P27, in lung adenocarcinoma.
    Goto A; Niki T; Moriyama S; Funata N; Moriyama H; Nishimura Y; Tsuchida R; Kato JY; Fukayama M
    Pathol Int; 2004 Sep; 54(9):675-81. PubMed ID: 15363035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FBXW7 suppresses epithelial-mesenchymal transition and chemo-resistance of non-small-cell lung cancer cells by targeting snai1 for ubiquitin-dependent degradation.
    Xiao G; Li Y; Wang M; Li X; Qin S; Sun X; Liang R; Zhang B; Du N; Xu C; Ren H; Liu D
    Cell Prolif; 2018 Oct; 51(5):e12473. PubMed ID: 30094882
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Skp2 directs Myc-mediated suppression of p27Kip1 yet has modest effects on Myc-driven lymphomagenesis.
    Old JB; Kratzat S; Hoellein A; Graf S; Nilsson JA; Nilsson L; Nakayama KI; Peschel C; Cleveland JL; Keller UB
    Mol Cancer Res; 2010 Mar; 8(3):353-62. PubMed ID: 20197382
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Short hairpin RNA-mediated down-regulation of CENP-A attenuates the aggressive phenotype of lung adenocarcinoma cells.
    Wu Q; Chen YF; Fu J; You QH; Wang SM; Huang X; Feng XJ; Zhang SH
    Cell Oncol (Dordr); 2014 Dec; 37(6):399-407. PubMed ID: 25228009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gain of circBRAF Represses Glioma Progression by Regulating miR-1290/FBXW7 Axis.
    Zhang J; Chen Z; Liu X; Yang C; Xie D
    Neurochem Res; 2021 May; 46(5):1203-1213. PubMed ID: 33650075
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NDRG2 facilitates colorectal cancer differentiation through the regulation of Skp2-p21/p27 axis.
    Shen L; Qu X; Li H; Xu C; Wei M; Wang Q; Ru Y; Liu B; Xu Y; Li K; Hu J; Wang L; Ma Y; Li M; Lai X; Gao L; Wu K; Yao L; Zheng J; Zhang J
    Oncogene; 2018 Mar; 37(13):1759-1774. PubMed ID: 29343851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Skp2 regulates non-small cell lung cancer cell growth by Meg3 and miR-3163.
    Su L; Han D; Wu J; Huo X
    Tumour Biol; 2016 Mar; 37(3):3925-31. PubMed ID: 26482610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LncRNA LINC00680 promotes lung adenocarcinoma growth via binding to GATA6 and canceling GATA6-mediated suppression of SOX12 expression.
    Sun X; Wang R; Tan M; Tian X; Meng J
    Exp Cell Res; 2021 Aug; 405(1):112653. PubMed ID: 34029572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FAM60A promotes cisplatin resistance in lung cancer cells by activating SKP2 expression.
    Hou Q; Jiang Z; Li Y; Wu H; Yu J; Jiang M
    Anticancer Drugs; 2020 Sep; 31(8):776-784. PubMed ID: 32796403
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Local injection of lentivirus-delivered livinshRNA suppresses lung adenocarcinoma growth by inducing a G0/G1 phase cell cycle arrest.
    Chen YS; Li HR; Miao Y; Chen WY; Li YT; Wang GQ; Wu ZC
    Int J Clin Exp Pathol; 2012; 5(8):796-805. PubMed ID: 23071862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altered expression of Skp2, c-Myc and p27 proteins but not mRNA after H. pylori eradication in chronic gastritis.
    Kim SS; Meitner P; Konkin TA; Cho YS; Resnick MB; Moss SF
    Mod Pathol; 2006 Jan; 19(1):49-58. PubMed ID: 16118628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of p27 by S-phase kinase-associated protein 2 is associated with aggressiveness in non-small-cell lung cancer.
    Osoegawa A; Yoshino I; Tanaka S; Sugio K; Kameyama T; Yamaguchi M; Maehara Y
    J Clin Oncol; 2004 Oct; 22(20):4165-73. PubMed ID: 15483027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.